00:49
ACGT grants helping scientists conduct crucial cancer studies
00:56
Cell and gene therapy for glioblastoma (brain cancer)
01:02
How CAR T cells are made to treat cancer
00:53
The unique aspect of cell and gene therapy for cancer
00:35
Supporting the cancer medicines of tomorrow
00:25
Dr. Daniel Powell: Clinical trial from ACGT funding
01:06
Cell and gene therapy: Investing in the future of cancer treatment
00:31
Our opportunity in cell and gene therapy research
00:52
ACGT funding de-risks innovative cancer research
01:03
Investing in all types of cancer cell and gene therapy
00:32
Every bit of funding from ACGT is critical for cancer research
00:26
Cancer cell and gene therapy provides better quality of life
01:05
How cell and gene therapy uses your own body to fight cancer
00:54
Teaming up the immune system with cell and gene therapy
00:56
How cell and gene therapy can treat cancer with one infusion
00:56
How cell and gene therapy tackles the challenges of cancer
00:40
The power of cell and gene therapy against cancer
00:35
How ACGT grants for cancer research are unique
00:51
Every dollar donated to ACGT goes to cancer research
00:40
ACGT's focus on cell and gene therapy
01:17
How ACGT funding solves the "valley of death" in cancer research
00:42
Need to focus cell and gene therapy research on solid tumors
00:25
Carl June explains significance of ACGT funding
00:37
Dr. Daniel Powell on grant from ACGT
00:55
Dr. Crystal Mackall on cell and gene therapy and ACGT's impact
00:54
Dr. Nino Chiocca on ACGT grant for oncolytic virus
00:53
Dr. Carl June on his revolutionary ACGT grant
00:19
Thanking ACGT Co-Founder Barbara Netter
00:34
Dr. Crystal Mackall on moving cancer research ideas forward
00:56
Brian Brown, PhD, on research grant from ACGT
00:27
How cancer funding can help future generations
00:46
Daniel Powell, PhD, on how people can get involved in advancing cancer research
00:26
Crystal Mackall, MD, on why to donate to ACGT
00:49
Thank you for helping ACGT reach its Giving Tuesday goal
01:10
Help ACGT meet our Giving Tuesday fundraising goal
01:00
ACGT funding the CAR T-cell revolution
01:25
ACGT's cell and gene therapy collaborations with biotech companies
01:06
What ACGT is funding in cell and gene therapy
01:10
ACGT's approach to funding cancer cell and gene therapy
00:43
George Yancopoulos, MD, PhD β Curative Therapies
01:29
Lotze, MD β A Cancer-Free Future
01:23
Samuel Katz, MD, PhD β Impact of Alliance for Cancer Gene Therapy (ACGT) Funding
00:59
Samuel Katz, MD, PhD β Impact of Alliance for Cancer Gene Therapy (ACGT) Funding
01:00
Carl June, MD β Patient Perspectives
00:51
Michael T. Lotze, MD β Discusses Alliance for Cancer Gene Therapy (ACGT) Leadership
00:50
John Bell, PhD β Greatest Outcomes Ever Seen
01:46
Swim Across America Fairfield County 2022 Open Water Swim
00:59
Carl June, MD β Talks Curative Therapies
01:08
Michael T. Lotze, MD β Biology Meets Immunology
00:54
Samuel Katz, MD, PhD β New EraβA Lot Yet to be Done
01:30
Crystal Mackall, MD β Impact of Alliance for Cancer Gene Therapy Funding
04:15
Gene Therapy 2.0: Immunotherapy for Cancer - A Discussion of New Treatments for Sarcoma and Beyond
02:40
Dr. Crystal Mackall & Importance of Funding from Non-Profits
03:50
Cancer Gene Therapy 2.0 - Osteosarcoma with Dr. Crystal Mackall
01:01:20
Cancer Gene Therapy 2.0: Immunotherapy for Cancer
03:40
Cancer Gene Therapy: The Next Chapter - Perspectives from the Frontline
01:20
Dr. Carl June Speaks About Future of CAR T Gene Therapy for Treating Cancer
01:39:35
Panel Discussion Cancer Gene Therapy: The Next Chapter - Perspectives from the Frontline
00:21
ACGT Immunotherapy & Dr. Laurence Cooper
02:36
Cancer Research Funding: ACGT Scientific Advisory Council Member Dr. Lieping Chen, Yale University
X
About
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapy -- also known as immunotherapy -- is destroying tumors in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGTβs rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer treatment options other than chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.
Visit www.acgtfoundation.org and please donate now!
Tags